Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thibaut Pelat

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of Molecular Biology|April 22, 2008
Improvement of an antibody neutralizing the anthrax toxin by simultaneous mutagenesis of its six hypervariable loopsEmmanuelle Laffly, Thibaut Pelat, Frédéric Cédrone, et al.
BMC Biotechnology|July 1, 2009
Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activityThibaut Pelat, Michael Hust, Martha Hale, et al.
Plos One|June 7, 2013
Mapping the epitopes of a neutralizing antibody fragment directed against the lethal factor of Bacillus anthracis and cross-reacting with the homologous edema factorPhilippe Thullier, Arnaud Avril, Jacques Mathieu, et al.
Toxins|March 24, 2022
Antibodies against Anthrax Toxins: A Long Way from Benchlab to the BedsideArnaud Avril, Jean-Nicolas Tournier, Jean-Charles Paucod, et al.
Journal of Molecular Biology|November 4, 2008
Germline humanization of a non-human primate antibody that neutralizes the anthrax toxin, by in vitro and in silico engineeringThibaut Pelat, Hugues Bedouelle, Anthony R Rees, et al.
BMC Biotechnology|June 19, 2015
Structural differences of amyloid-β fibrils revealed by antibodies from phage displayPatrick Droste, André Frenzel, Miriam Steinwand, et al.
Mabs|February 13, 2014
Human-like antibodies neutralizing Western equine encephalitis virusBirgit Hülseweh, Torsten Rülker, Thibaut Pelat, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2007
High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formationThibaut Pelat, Michael Hust, Emmanuelle Laffly, et al.
BMC Biotechnology|November 25, 2011
Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque originSiham Chahboun, Michael Hust, Yvonne Liu, et al.
BMC Biotechnology|September 19, 2015
Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A1 and A2 by targeting their heavy chainArnaud Avril, Sebastian Miethe, Michel R Popoff, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Molecular Biology|April 22, 2008
Improvement of an antibody neutralizing the anthrax toxin by simultaneous mutagenesis of its six hypervariable loopsEmmanuelle Laffly, Thibaut Pelat, Frédéric Cédrone, et al.
BMC Biotechnology|July 1, 2009
Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activityThibaut Pelat, Michael Hust, Martha Hale, et al.
Plos One|June 7, 2013
Mapping the epitopes of a neutralizing antibody fragment directed against the lethal factor of Bacillus anthracis and cross-reacting with the homologous edema factorPhilippe Thullier, Arnaud Avril, Jacques Mathieu, et al.
Toxins|March 24, 2022
Antibodies against Anthrax Toxins: A Long Way from Benchlab to the BedsideArnaud Avril, Jean-Nicolas Tournier, Jean-Charles Paucod, et al.
Journal of Molecular Biology|November 4, 2008
Germline humanization of a non-human primate antibody that neutralizes the anthrax toxin, by in vitro and in silico engineeringThibaut Pelat, Hugues Bedouelle, Anthony R Rees, et al.
BMC Biotechnology|June 19, 2015
Structural differences of amyloid-β fibrils revealed by antibodies from phage displayPatrick Droste, André Frenzel, Miriam Steinwand, et al.
Mabs|February 13, 2014
Human-like antibodies neutralizing Western equine encephalitis virusBirgit Hülseweh, Torsten Rülker, Thibaut Pelat, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2007
High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formationThibaut Pelat, Michael Hust, Emmanuelle Laffly, et al.
BMC Biotechnology|November 25, 2011
Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque originSiham Chahboun, Michael Hust, Yvonne Liu, et al.
BMC Biotechnology|September 19, 2015
Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A1 and A2 by targeting their heavy chainArnaud Avril, Sebastian Miethe, Michel R Popoff, et al.
Pageof 4